Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 8;13(6):1972.
doi: 10.3390/nu13061972.

Inflammation and the Association of Vitamin D and Depressive Symptomatology

Affiliations

Inflammation and the Association of Vitamin D and Depressive Symptomatology

Ezgi Dogan-Sander et al. Nutrients. .

Abstract

Depression and vitamin D deficiency are major public health problems. The existing literature indicates the complex relationship between depression and vitamin D. The purpose of this study was to examine whether this relationship is moderated or mediated by inflammation. A community sample (n = 7162) from the LIFE-Adult-Study was investigated, for whom depressive symptoms were assessed via the German version of CES-D scale and serum 25-hydroxyvitamin D (25(OH)D) levels and inflammatory markers (IL-6 and CRP levels, WBC count) were quantified. Mediation analyses were performed using Hayes' PROCESS macro and regression analyses were conducted to test moderation effects. There was a significant negative correlation between CES-D and 25(OH)D, and positive associations between inflammatory markers and CES-D scores. Only WBC partially mediated the association between 25(OH)D levels and depressive symptoms both in a simple mediation model (ab: -0.0042) and a model including covariates (ab: -0.0011). None of the inflammatory markers showed a moderation effect on the association between 25(OH)D levels and depressive symptoms. This present work highlighted the complex relationship between vitamin D, depressive symptoms and inflammation. Future studies are needed to examine the effect of vitamin D supplementation on inflammation and depressive symptomatology for causality assessment.

Keywords: LIFE-Adult-Study; depression; inflammation; mediation; moderation; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of data selection process. BMI: body mass index, CES-D: German version of the Centre for Epidemiological Studies Depression Scale [30], 25(OH)D: 25-Hydroxyvitamin D.
Figure 2
Figure 2
Mediation model without (a) and with covariates (b) showing both the total and direct effect of serum 25(OH)D concentrations on the intensity of depressive symptomatology as measured by CES-D sum scores (path coefficients c and c′) and the indirect effect of serum 25(OH)D concentrations on CES-D scores mediated through c-reactive protein (CRP) concentrations (path coefficient ab) in the study sample. The figures depict the unstandardized path coefficients (a,b,c,c′ and ab; with ** p < 0.010; *** p < 0.001).
Figure 3
Figure 3
Mediation model without (a) and with covariates (b) showing both the total and direct effect of serum 25(OH)D concentrations on the intensity of depressive symptomatology as measured by CES-D sum scores (path coefficients c and c′) and the indirect effect of serum 25(OH)D concentrations on CES-D scores mediated through interleukin 6 (IL-6) concentrations (path coefficient ab) in the study sample. The figure depicts the unstandardized path coefficients (a,b,c,c′ and ab; with * p < 0.050; ** p < 0.010; *** p < 0.001).
Figure 4
Figure 4
Mediation model without (a) and with covariates (b) showing both the total and direct effect of serum 25(OH)D concentrations on the intensity of depressive symptomatology as measured by CES-D sum scores (path coefficients c and c′) and the indirect effect of serum 25(OH)D concentrations on CES-D scores mediated through white blood cell (WBC) count (path coefficient ab) in the study sample. The figure depicts the unstandardized path coefficients (a,b,c,c′ and ab; with ** p < 0.010; *** p < 0.001).

Similar articles

Cited by

References

    1. Lim G.Y., Tam W.W., Lu Y., Ho C.S., Zhang M.W., Ho R.C. Prevalence of Depression in the Community from 30 Countries between 1994 and 2014. Sci. Rep. 2018;8:1–10. doi: 10.1038/s41598-018-21243-x. - DOI - PMC - PubMed
    1. James S.L., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analy-sis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7. Erratum in 2019, 393, e44. - DOI - PMC - PubMed
    1. Cuijpers P., Beekman A.T.F., Reynolds C.F., 3rd Preventing Depression: A global priority. JAMA. 2012;307:1033–1034. doi: 10.1001/jama.2012.271. Erratum in 2012, 307, 2259. - DOI - PMC - PubMed
    1. Cashman K.D., Dowling K.G., Škrabáková Z., Gonzalez-Gross M., Valtueña J., De Henauw S., Moreno L., Damsgaard C.T., Michaelsen K.F., Mølgaard C., et al. Vitamin D deficiency in Europe: Pandemic? Am. J. Clin. Nutr. 2016;103:1033–1044. doi: 10.3945/ajcn.115.120873. - DOI - PMC - PubMed
    1. Anglin R.E.S., Samaan Z., Walter S.D., McDonald S.D. Vitamin D deficiency and depression in adults: Systematic review and meta-analysis. Br. J. Psychiatry. 2013;202:100–107. doi: 10.1192/bjp.bp.111.106666. - DOI - PubMed